Generic-Reglan Suits Doomed By Catch-22, 6th Circ. Says
By Michael Lipkin
Law360, Los Angeles (December 2, 2013, 6:13 PM ET) -- A Sixth Circuit panel on Monday refused to revive seven lawsuits alleging a generic version of digestion medication Reglan caused users to develop a serious neurological condition, ruling the plaintiffs were caught in a catch-22 preventing them from bringing claims against generic or brand-name manufacturers.
Writing for the panel U.S. Circuit Judge Ronald Lee Gilman, upheld a lower court's decision dismissing the cases on the grounds that the plaintiffs had taken metoclopramide, the generic name for Reglan, and brand-name manufacturers couldn’t be held liable under the...